Drug Profile
CP 642959
Alternative Names: CP-642959Latest Information Update: 07 Feb 2006
Price :
$50
*
At a glance
- Originator Pfizer
- Class Antibacterials; Ketolides
- Mechanism of Action Protein 50S ribosomal subunit inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Bacterial infections
Most Recent Events
- 07 Feb 2006 No development reported - Preclinical for Bacterial infections in USA (PO)
- 03 Jan 2002 Preclinical development for Bacterial infections in USA (PO)